In 1996, Samson and colleagues reported that a 32-base-pair deletion mutant of CCR5 (CCR5Δ32) confers resistance to HIV-1 infection in CD4+ cells (Samson et al., 1996). This evidence concerns the gene CD4 and HIV-1 infection.